Streetbeat News

Regulatory

MSTR

Dogecoin (DOGE) has seen a 16.3% increase over the past week, coinciding with broader cryptocurrency market strength. Bitcoin's surge past $40,000, following MicroStrategy's purchase of 16,130 Bitcoins, has positively influenced altcoins, including Dogecoin. The SEC's consideration of a rule change for a Fidelity Ethereum ETF also suggests growing institutional interest in cryptocurrencies, which could further boost altcoin prices like Dogecoin.

Portfolio Pulse from Henry Khederian

December 05, 2023 | 12:10 am

VNDA

Vanda Pharmaceuticals announced that the FDA has accepted its New Drug Application for Tradipitant, aimed at treating Gastroparesis. The FDA's decision is expected by September 18, 2024. If approved, Tradipitant would be the first novel drug for Gastroparesis approved in over 40 years.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 11:02 pm

PRSR

LeddarTech and Prospector Capital announced the effectiveness of their registration statement and scheduled an Extraordinary General Meeting for December 13, 2023, to approve their business combination. This step is crucial for the merger process, which will result in LeddarTech becoming a publicly traded company through Prospector Capital's SPAC structure.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 10:32 pm

BTC-USD

ETC-USD

MSTR

Ethereum Classic (ETC) has seen a 7.8% increase over the past week, amidst a broader cryptocurrency market strength. Bitcoin (BTC) soared above $40,000 after MicroStrategy purchased 16,130 Bitcoins, reinforcing investor trust in cryptocurrencies. The SEC is considering a rule change for a Fidelity spot Ethereum ETF, indicating growing institutional interest in crypto. While not directly impacting Ethereum Classic, these developments could boost sentiment for ETC as well.

Portfolio Pulse from Henry Khederian

December 04, 2023 | 10:23 pm

PTN

Palatin Technologies has filed with the SEC for the potential sale of up to 2,476,416 shares of common stock by selling shareholders. This filing allows these shareholders to sell their shares in the market, although it does not necessarily mean that all the shares will be sold or that they will be sold immediately.

Portfolio Pulse from Charles Gross

December 04, 2023 | 10:04 pm

SOFO

Sonic Foundry's stock (SOFO) is trading lower following the announcement of its impending delisting from the Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 9:37 pm

JNJ

The U.S. FDA has granted Breakthrough Therapy Designation (BTD) to Johnson & Johnson's TAR-200 for the treatment of high-risk non-muscle-invasive bladder cancer (HR-NMIBC). TAR-200 is an investigational targeted releasing system for sustained local release of gemcitabine. The designation is based on data from the ongoing Phase 2b SunRISe-1 study, which also evaluates cetrelimab, a PD-1 monoclonal antibody. The BTD aims to expedite the development and review of treatments for serious conditions showing substantial improvement over existing therapies.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 9:33 pm

AEY

ADDvantage Technologies Group, Inc. (NASDAQ:AEY) has regained compliance with Nasdaq's minimum bid price requirement after its stock closed at $1.00 or higher for 10 consecutive business days. The company had previously been notified of non-compliance due to its stock price falling below $1.00 for 30 consecutive business days.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 9:23 pm

MMSI

Merit Medical Systems, Inc. (MMSI) plans to offer $550 million in Convertible Senior Notes due 2029 to qualified institutional buyers, with an option for an additional $82.5 million. The notes are senior unsecured obligations with semiannual interest. Upon conversion, Merit may pay in cash, stock, or a mix. Proceeds will fund general corporate purposes, potential acquisitions, and capped call transactions to minimize dilution from conversions. The notes and any shares from conversions are not registered under the Securities Act and are subject to Rule 144A.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 9:23 pm

AAMC

Altisource Asset Management Corporation (AAMC) received a notice from the NYSE on November 30, 2023, indicating that AAMC's common stock will be delisted due to non-compliance with listing standards. AAMC intends to appeal the decision within the required seven-day period. The outcome of the appeal is uncertain, and further announcements will be made post-appeal regarding the stock's listing status.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 9:19 pm